{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T01:55:31Z","timestamp":1767664531738},"reference-count":25,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":9306,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Haematology"],"published-print":{"date-parts":[[1983,11]]},"abstract":"<jats:p>Sera from 63 patients with haemophilia A, 21 with haemophilia B and 29 with von Willebrand's disease were screened for the presence of circulating immune complexes (CICs), serological markers of hepatitis A and B virus, autoantibodies and factor VIII or factor IX inhibitors. CICs were detected by the <jats:sup>125<\/jats:sup>J Clq binding assay (ClqBA), the solid phase conglutinin assay (KgBSP) and the solid phase Clq assay (ClqSP).<\/jats:p><jats:p>The incidence of CICs detected by the ClqBA and the ClqSP methods in haemophiliacs and in von Willebrand patients was higher than that observed in normal subjects, while the prevalence of CICs detected by the KgBSP method was not. The presence of CICs was not correlated with patient age, severity of disease, presence of hepatitis B virus serological markers, abnormal liver function tests or factor VIII inhibitors. A significant connection was demonstrated between CICs detected by the ClqBA method and replacement therapy when the dose administered over 1 year was over 20000 U of factor VIII or IX concentrates. The high proportion of CICs in von Willebrand's disease, not connected with the replacement therapy or the presence of serological markers of hepatitis virus, is in agreement with the possibility that immune complexes may be related to the disease itself and independent, at least in part, of exogenous agents.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1983.tb01545.x","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T18:49:46Z","timestamp":1280947786000},"page":"466-474","source":"Crossref","is-referenced-by-count":5,"title":["Circulating Immune Complexes in Haemophilia and von Willebrand's Disease"],"prefix":"10.1111","volume":"31","author":[{"given":"A.","family":"Passaleva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Massai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Morfini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. L. Rossi","family":"Ferrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197412262912604"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.28.8.620"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1976.03630070040012"},{"key":"e_1_2_1_5_2","first-page":"143","volume-title":"Unresolved problems in haemophilia","author":"Hilgartner MW.","year":"1980"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.30.12.1142"},{"key":"e_1_2_1_7_2","first-page":"315","article-title":"Circulating immune complexes containing anti\u2010VIII antibodies in multi\u2010transfused patients with haemophilia A","volume":"39","author":"Kazatchkine MD","year":"1980","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_8_2","unstructured":"MassaiG. MontantiC. MorfiniM. LeonciniF. PassalevaA.Marcatori del virus epatitico B e immunocomplessi circolanti in pazienti emofilici. In: Proceedings of V Congress Societ\u00e0 Italiana di Immunologia e Immunopatologia Florence November 2729 1980;72."},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1055\/s-0038-1653455","article-title":"Circulating immune complexes pre\u2010 and post\u2010clotting factor infusion in haemophilia","volume":"46","author":"Gomperts ED","year":"1981","journal-title":"Tromb Haemost"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830110205"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4049\/jimmunol.116.1.232","article-title":"Detection of immune complexes in unheated sera by a modified 125J\u2010Clq binding test","volume":"116","author":"Zubler RH","year":"1976","journal-title":"J Immunol"},{"key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.4049\/jimmunol.118.4.1428","article-title":"Use of bovine conglutinin for the assay of immune complexes","volume":"118","author":"Eisenberg RA","year":"1977","journal-title":"J Immunol"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1977.tb00362.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(72)90014-2"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2423(08)60415-1"},{"key":"e_1_2_1_16_2","first-page":"869","article-title":"A more uniform measurement of factor VIII inhibitors","volume":"34","author":"Kasper CK","year":"1975","journal-title":"Thromb Diat Haemorrh"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1974.tb00476.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)90688-1"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)90945-0"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198010163031619"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-86-6-703"},{"key":"e_1_2_1_22_2","first-page":"41","volume-title":"Unresolved problems in haemophilia","author":"Preston FE","year":"1980"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/217174a0"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V40.1.1.1","article-title":"Immunochemical characterization of a monoclonal \u03b3G4, ****\u03bb human antibody to factor IX","volume":"40","author":"Pike IM","year":"1972","journal-title":"Blood"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(70)80056-0"},{"key":"e_1_2_1_26_2","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1182\/blood.V48.6.931.931","article-title":"Characterization of human anti\u2010factor VIII antibodies purified by immunecomplex formation","volume":"48","author":"Lavergne JM","year":"1976","journal-title":"Blood"}],"container-title":["Scandinavian Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1983.tb01545.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1983.tb01545.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T20:34:10Z","timestamp":1697747650000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1983.tb01545.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,11]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1983,11]]}},"alternative-id":["10.1111\/j.1600-0609.1983.tb01545.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1983.tb01545.x","archive":["Portico"],"relation":{},"ISSN":["0036-553X"],"issn-type":[{"value":"0036-553X","type":"print"}],"subject":[],"published":{"date-parts":[[1983,11]]}}}